As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

The SCORPIO-PEP trial found the drug ensitrelvir, already approved in Japan to treat people ... Those who took a five-day course of ensitrelvir after exposure to COVID-19 were less likely to get sick, ...

It doesn’t have the drug-drug interactions that prevent many people with COVID-19 from taking Paxlovid. And participants in ibuzatrelvir’s Phase 2 clinical trial didn’t report “Paxlovid ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

Researchers at Rutgers University have created a new antiviral drug for COVID-19 that could be safer and more effective than Paxlovid, the current leading treatment. The new drug, called Jun13296, may ...

It has been five years since I saw my first COVID-19 patient here in St. Lucie County. It was a 90-year-old woman, who ...

Scientists at Rutgers Health have developed a new COVID-19 drug that could be a powerful alternative to Paxlovid, the most commonly used oral treatment for the virus. This new drug, called Jun13296, ...

Johnson & Johnson’s pharmaceutical arm, Janssen, has shared early preclinical findings on its new antiviral drug, JNJ-9676, which shows promise in combating COVID-19 and other serious coronaviruses.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its ...